Success Story: Gastroenterology Researcher Secures I-140 NIW Approval Without an RFE Thanks to Our Strategic Filing

 

Client’s Testimonial:

"The overall process was very smooth. Proper and honest guidance was given. Response was always very prompt. I am now very excited to start the process for EB-1A. Thank you!”


On February 20th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Physician Gastroenterologist in the Field of Gastroenterology (Approval Notice).


General Field: Gastroenterology

Position at the Time of Case Filing: Physician, Gastroenterologist

Country of Origin: India

State of Residence at the Time of Filing: Ohio

Approval Notice Date: February 20th, 2026

Processing Time: 1 month, 20 days (Premium Processing Upgrade Requested)


Case Summary:  

Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our team secured an I-140 NIW approval for a physician-researcher in gastroenterology whose work focuses on earlier diagnosis of serious gastrointestinal conditions and improved patient access to effective care. The case highlighted the client’s research on ambulatory rectal sensor devices and clinical trials designed to stratify esophageal cancer risk, a proposed endeavor with clear substantial merit and national importance.

Client Background and Expertise  With an M.B.B.S., the client has built a strong profile in gastroenterology and clinical research. At the time of filing, the client was engaged in clinical and research work in the United States. His proposed endeavor centers on developing less invasive diagnostic tools and clinical trial strategies that can support earlier identification of disease, improve treatment access, reduce healthcare costs, and strengthen quality of life for affected patients. In the petition, we showed that this work carries national importance because it addresses a serious cancer burden while also supporting more efficient and accessible care.

Exceptional Credentials  The client’s qualifications include: ● 9 peer-reviewed journal articles, including 1 co-first-authored article ● 31 conference abstracts, including 7 first-authored abstracts ● 1 first-authored book chapter ● 757 citations ● At least 25 peer reviews

These metrics were not treated as self-proving. Instead, we presented them as objective indicators of independent reliance and professional trust. The publication record showed sustained scholarly output, the citation count reflected that other researchers had found the client’s work useful enough to build upon, and the peer review activity demonstrated recognized expertise within the field.

Approval Outcome  The I-140 NIW petition was approved based on a record showing that the client’s research is both important in substance and well supported by evidence of impact, credibility, and future positioning. It was a privilege to support this case, and we extend our sincere best wishes for the client’s continued success in advancing gastroenterological research in the United States.